sponsored
PatientsVille.com Logo

PatientsVille

Lotemax Medical Research Studies

Up-to-date List of Lotemax Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Lotemax Medical Research Studies

Rank Status Study
1 Recruiting Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Conditions: Inflammation;   Pain;   Cataract
Interventions: Drug: Loteprednol Etabonate Gel (BID);   Drug: Loteprednol Etabonate Gel (TID);   Drug: Vehicle (BID);   Drug: Vehicle (TID)
Outcome Measures: Resolution of AC Cells;   Pain;   Resolution of AC cells;   Resolution of AC Flare;   Resolution of AC Cells and Flare
2 Not yet recruiting Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
Outcome Measures: Clinical cure;   irradication of pathogens
3 Recruiting Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease
Condition: Dry Eye Syndrome
Interventions: Drug: loteprednol etabonate (Lotemax);   Drug: Soothe Tired Eyes Lubricant Eye Drop
Outcome Measure: To evaluate the efficacy of Lotemax as compared to Soothe Tired Eyes Lubricant Eye Drop , using clinical and in vivo confocal microscopic findings.
4 Unknown  Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Conditions: Pseudophakia;   Cataract Surgery
Interventions: Drug: Pred Forte;   Drug: Lotemax
Outcome Measure: Prevention Of Retinal Thickening
5 Recruiting The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: Lotemax;   Drug: Artificial Tears
Outcome Measures: In Vivo Confocal Microscopy (IVCM): Superficial corneal epithelial cells: Density, size, and hypereflectivity;   In Vivo Confocal Microscopy: Corneal subbasal immune dendritiform cells: Density, size, and cell field;   In Vivo Confocal Microscopy: Corneal subbasal nerves: Number and length of the main nerves and the branches;   Ocular Signs: Corneal epitheliopathy;   Ocular Signs: Conjunctival epitheliopathy;   Ocular Signs: Tear Break Up Time (TBUT);   Ocular Signs: Schirmer's Test with Anesthesia;   Ocular Signs: Intraocular pressure (IOP) by measure of applanation tonometry;   Ocular Symptoms: Ocular Surface Disease Index (OSDI) questionnaire;   Ocular Symptoms: • Symptom Assessment iN Dry Eye (SANDE) questionnaire
6 Recruiting Efficacy of Loteprednol Ointment Following Eyelid Surgery
Condition: Post-operative Healing Following Blepharoplasty and Ptosis Repair
Interventions: Drug: Loteprednol etabonate ophthalmic ointment;   Drug: Vehicle Ophthalmic Ointment
Outcome Measure: Inflammation
7 Recruiting Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
Condition: Cataract
Interventions: Drug: Loteprednol etabonate;   Drug: Prednisolones acetate
Outcome Measures: Anterior Chamber Inflammation;   Anterior Chamber Cells & Flare
8 Recruiting A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Condition: Dry Eye Disease
Interventions: Drug: Loteprednol etabonate;   Drug: Artificial Tears;   Drug: Restasis
Outcome Measures: Fluorescein corneal staining scores;   Lissamine green conjunctival staining
9 Recruiting Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Conditions: Fuchs' Dystrophy;   Corneal Edema
Interventions: Drug: loteprednol etabonate;   Drug: prednisolone acetate 1%
Outcome Measures: Change from baseline intraocular pressure;   Immunologic graft rejection episode
10 Unknown  A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
Condition: Intraocular Inflammation
Intervention:
Outcome Measures: Intraocular inflammation grading;   Intraocular pressure spikes

These studies may lead to new treatments and are adding insight into Lotemax etiology and treatment.

A major focus of Lotemax research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Lotemax